{"id":"https://openalex.org/W2149138665","doi":"https://doi.org/10.1176/ajp.156.12.1931","title":"A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder","display_name":"A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder","publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W2149138665","doi":"https://doi.org/10.1176/ajp.156.12.1931","mag":"2149138665","pmid":"https://pubmed.ncbi.nlm.nih.gov/10588407"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.156.12.1931","doi":"https://doi.org/10.1176/ajp.156.12.1931","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.156.12.1931","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000660066","display_name":"Timothy E. Wilens","orcid":"https://orcid.org/0000-0002-5749-8503","observed_orcids":["https://orcid.org/0000-0002-5749-8503"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy E. Wilens","raw_affiliation_strings":["Pediatric Psychopharmacology Clinic, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. wilens@helix.mgh.harvard.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Psychopharmacology Clinic, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. wilens@helix.mgh.harvard.edu","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070269405","display_name":"Joseph Biederman","orcid":"https://orcid.org/0000-0001-8233-663X","observed_orcids":["https://orcid.org/0000-0001-8233-663X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Biederman","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas J. Spencer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J. Spencer","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004125740","display_name":"Jeff Q. Bostic","orcid":"https://orcid.org/0000-0002-0040-6612","observed_orcids":["https://orcid.org/0000-0002-0040-6612"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff Bostic","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028349876","display_name":"Jefferson B. Prince","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jefferson Prince","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075209314","display_name":"Michael Carl Monuteaux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael C. Monuteaux","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111962668","display_name":"J. Soriano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Soriano","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109887223","display_name":"C Fine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Fine","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007079849","display_name":"Annah N. Abrams","orcid":"https://orcid.org/0000-0003-2681-3328","observed_orcids":["https://orcid.org/0000-0003-2681-3328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annah Abrams","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003828192","display_name":"Michael A. Rater","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Rater","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055032027","display_name":"David A. Polisner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Polisner","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.7662,"has_fulltext":false,"cited_by_count":228,"citation_normalized_percentile":{"value":0.97926156,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"156","issue":"12","first_page":"1931","last_page":"1937"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abt-418","display_name":"ABT-418","score":0.8949999809265137},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.8640000224113464},{"id":"https://openalex.org/keywords/adult-adhd","display_name":"adult ADHD","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cholinergic-agonists","display_name":"cholinergic agonists","score":0.8889999985694885},{"id":"https://openalex.org/keywords/nicotinic-agonists","display_name":"nicotinic agonists","score":0.8529999852180481},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.652999997138977},{"id":"https://openalex.org/keywords/adhd-symptom-improvement","display_name":"ADHD symptom improvement","score":0.6150000095367432},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6273757219314575},{"id":"https://openalex.org/C11171543","wikidata":"https://www.wikidata.org/wiki/Q41630","display_name":"Psychoanalysis","level":1,"score":0.42366108298301697},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41521212458610535},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4045674204826355},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.292709618806839}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004244","descriptor_name":"Dizziness","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018679","descriptor_name":"Cholinergic Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018679","descriptor_name":"Cholinergic Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018679","descriptor_name":"Cholinergic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1176/ajp.156.12.1931","doi":"https://doi.org/10.1176/ajp.156.12.1931","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.156.12.1931","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:10588407","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10588407","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G3752812204","display_name":"ADDICTIVE DISORDER RISK IN CHILDREN--PSYCHOPATHOLOGY","funder_award_id":"K20MH001175","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W10325908","https://openalex.org/W74971179","https://openalex.org/W616784798","https://openalex.org/W1730181129","https://openalex.org/W1853594963","https://openalex.org/W1965364483","https://openalex.org/W1979465426","https://openalex.org/W1989428478","https://openalex.org/W1994039822","https://openalex.org/W1995640389","https://openalex.org/W1995686738","https://openalex.org/W1998699408","https://openalex.org/W2021274116","https://openalex.org/W2037281804","https://openalex.org/W2041100912","https://openalex.org/W2045122897","https://openalex.org/W2045964508","https://openalex.org/W2046843095","https://openalex.org/W2047530246","https://openalex.org/W2048118408","https://openalex.org/W2048278155","https://openalex.org/W2057791286","https://openalex.org/W2060201075","https://openalex.org/W2067495470","https://openalex.org/W2068987805","https://openalex.org/W2069804804","https://openalex.org/W2074362223","https://openalex.org/W2079590493","https://openalex.org/W2085158965","https://openalex.org/W2090773271","https://openalex.org/W2093507141","https://openalex.org/W2098814699","https://openalex.org/W2100773070","https://openalex.org/W2114613490","https://openalex.org/W2115005692","https://openalex.org/W2133700875","https://openalex.org/W2142881539","https://openalex.org/W2143384791","https://openalex.org/W2145872963","https://openalex.org/W2160070901","https://openalex.org/W2160971639","https://openalex.org/W2206837868","https://openalex.org/W2219410410","https://openalex.org/W2222886669","https://openalex.org/W2238102071","https://openalex.org/W2396755452","https://openalex.org/W2415125145","https://openalex.org/W2463562349","https://openalex.org/W2809683597","https://openalex.org/W3217490374"],"related_works":["https://openalex.org/W2521111895","https://openalex.org/W2069324192","https://openalex.org/W2044210997","https://openalex.org/W2109356111","https://openalex.org/W2060163547","https://openalex.org/W2093484941","https://openalex.org/W2001767344","https://openalex.org/W1992244279","https://openalex.org/W2048740041","https://openalex.org/W31743634"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Despite":[1],"the":[2,25,36,50,98,103,118,121,193,218],"increasing":[3],"recognition":[4],"of":[5,17,28,42,52,70,94,123,135,169,202,220],"attention":[6],"deficit":[7],"hyperactivity":[8],"disorder":[9],"(ADHD)":[10],"in":[11,76,102,159],"adults,":[12],"there":[13,153],"is":[14],"a":[15,39,44,59,67,131,155,208,213],"paucity":[16],"controlled":[18,40],"pharmacological":[19],"trials.":[20],"Recent":[21],"reports":[22],"have":[23],"suggested":[24],"potential":[26],"usefulness":[27],"cholinergic":[29,46],"agents":[30],"for":[31,49,82,217],"ADHD.":[32,55,83,221],"To":[33],"this":[34,203],"end,":[35],"authors":[37],"completed":[38,117],"study":[41,104],"ABT-418,":[43,207],"novel":[45],"activating":[47],"agent,":[48],"treatment":[51,88,219],"adults":[53,77],"with":[54,173,183],"METHOD:":[56],"This":[57],"was":[58,137,154,185],"double-blind,":[60],"placebo-controlled,":[61],"randomized,":[62],"crossover":[63],"trial":[64],"that":[65,206],"compared":[66],"transdermal":[68],"patch":[69],"ABT-418":[71,142,184],"(75":[72],"mg/day)":[73],"to":[74,180],"placebo":[75,146],"who":[78],"met":[79],"DSM-IV":[80],"criteria":[81],"There":[84],"were":[85,106,192],"two":[86],"3-week":[87],"periods":[89],"separated":[90],"by":[91],"1":[92],"week":[93],"washout.":[95],"RESULTS:":[96],"Of":[97],"32":[99],"subjects":[100,136,172],"enrolled":[101],"(88%":[105],"men;":[107],"mean":[108],"age":[109],"=":[110,114],"40":[111],"years,":[112],"SD":[113],"9),":[115],"29":[116],"study.":[119],"At":[120],"endpoint":[122,152],"each":[124],"active":[125],"arm":[126],"(last":[127],"observation":[128],"carried":[129],"forward),":[130],"significantly":[132,156],"higher":[133],"proportion":[134],"considered":[138],"improved":[139],"while":[140,144],"receiving":[141,145],"than":[143],"(40%":[147],"versus":[148,165],"13%).":[149],"Similarly,":[150],"at":[151],"greater":[157],"reduction":[158],"ADHD":[160],"symptom":[161],"checklist":[162],"scores":[163],"(28%":[164],"15%).":[166],"Symptoms":[167],"reflective":[168],"attention,":[170],"and":[171,190],"less":[174],"severe":[175],"ADHD,":[176],"responded":[177],"more":[178],"robustly":[179],"ABT-418.":[181],"Treatment":[182],"relatively":[186],"well":[187],"tolerated;":[188],"dizziness":[189],"nausea":[191],"most":[194],"frequently":[195],"reported":[196],"adverse":[197],"effects.":[198],"CONCLUSIONS:":[199],"The":[200],"results":[201],"investigation":[204],"indicate":[205],"nicotinic":[209],"analog,":[210],"may":[211],"be":[212],"potentially":[214],"useful":[215],"agent":[216]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}